Search results - 6 results
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
cytologically abnormal specimens (100 atypical squamous cells of unspecified significance, 100 low-grade squamous intraepithelial lesions, 97 high-grade squamous intraepithelial lesions). Cases were defined as ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
Atypical Squamous Cells of the Cervix Cyclin-Dependent Kinase Inhibitor p16 Cytodiagnosis Early Detection of Cancer Female Humans immunohistochemistry Ki-67 Antigen Papillomaviridae Papillomavirus Infections ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
VALGENT is designed to assess the analytical and clinical performance of HPV tests with genotyping capacity. The VALGENT-3 panel comprised 1300 consecutive cervical cell specimens enriched with 300 samples ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
attributable fraction and type distribution of human papillomavirus (HPV) in head and neck squamous cell carcinomas by doing a systematic review and meta-analysis. METHODS We did a literature search on PubMed to ...
Cytological screening for cervical cancer in the province of Limburg, Belgium.
Prev, Volume 20, Issue 1, p.18-24 (2011) Keywords: Adult Belgium Female Humans Mass Screening middle aged Neoplasms, Squamous Cell Papanicolaou Test REGISTRIES Uterine Cervical Neoplasms Vaginal Smears ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Adult Belgium Carcinoma, Squamous Cell Child Female Guideline Adherence HEALTH POLICY Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Insurance, Health, Reimbursement ...